Participated · Series A · Feb 2026

Founded in 2009 in Durango by Daudi Barnes, Agile Space Industries builds high-performance chemical propulsion systems, using metal additive manufacturing and extensive in-house test facilities. The company supports a broad spectrum of commercial, civil, and national security space missions with its rocket engines and related hardware. In 2023, Agile expanded its Durango-La Plata County Airport footprint to 40,000 square feet and plans further growth in Colorado and Oklahoma. Revenue has more than tripled in the past three years, rising from about $8 million in 2022 to $28 million projected for 2026, and the business has grown over 70% annually since 2020. With the new capital, management intends to scale from developing two to three engines per year to six or more and boost tank and engine delivery capacity nearly tenfold. The company positions itself as a critical domestic supplier at a time when U.S. demand for chemical propulsion is rising.

Participated · Equity · Dec 2025

Empathy Health Technologies is the company behind Sober Sidekick, a free mobile application that connects individuals battling substance-use disorders with a 24/7 peer community, daily motivation, professional help and on-demand AA meetings. The app encourages users to both give and receive supportive messages and leverages an “empathy algorithm” that analyzes behavioral and language patterns to predict relapse risk, automatically triggering outreach when danger signs surface. Sober Sidekick has been downloaded nearly 1.1 million times, serves more than 145,000 monthly active users and has facilitated over 2 million peer interactions; an independent analysis found that five interactions on the platform correlate with a 68 % lower likelihood of relapse. While anyone can download the app for free, the company also signs value-based contracts with commercial and public payers. Revenue details were not disclosed, but Empathy Health intends to build a continuous-care infrastructure that shifts reimbursement from crisis response to relapse prevention. With its newest capital, the firm plans to deepen payer partnerships, enhance its predictive technology, and expand member-support operations, including data-science capacity and care-navigation infrastructure. Founded by CEO Chris Thompson, who drew on his own recovery experience, the company ultimately aims to redefine success in substance-use care by measuring sustained relapse prevention rather than episodic treatment.

Participated · Seed · Mar 2025

Equipt.ai is an AI-powered asset and field service management platform that streamlines and automates complex quote-to-job execution. The platform leverages embedded AI (EGenie) to maximize asset utilization, enable faster and more accurate invoicing, and minimize downtime through real-time tracking of shop and field operations. It manages technician competency, service tools, and complex asset-service packaging while offering seamless enterprise integration and sustainability-driven operational insights. The company highlights customer impact — Energy Water Solutions reported replacing three systems and improving operational efficiency by 33% after adopting Equipt. Leadership says it will advance Self-Service and Connectivity across people and processes as part of its product roadmap. Equipt recently closed a $3.2 million Seed round to fund product innovation, market expansion, and operational scaling.

Participated · Series B · Mar 2025

Lumata Health provides a human-led, technology-driven care management platform that combines predictive analytics with hundreds of certified ophthalmic care coaches to improve treatment adherence for chronic eye diseases. The platform delivers tailored interventions and partners with physicians, payers, and pharmaceutical manufacturers to enhance clinical outcomes and patient satisfaction. Lumata has partnered with eye care providers across the U.S., including the five largest national and regional eye care networks. The company reports that its proactive model has recently demonstrated up to 800 additional vision-saving eye injections annually for every 1,000 participating patients. Lumata plans to use the new funding to meet growing demand and further enhance the data-driven technology powering its patient adherence solutions. Founded in 2017 and based in Raleigh, N.C., the company has raised $36 million to date. Lumata Health offers an Intelligent Engagement Platform and a human-led continuous care program that combines behavioral information with clinical data to deliver tailored interventions through trained ophthalmic care coaches. The platform was developed with over $2MM in support from the National Eye Institute and is almost always free to patients. Programs are reimbursable under Medicare’s Chronic Care Management billing codes and are covered by secondary, supplement, or Medicare Advantage plans. Clinics using Lumata’s services have reported a 60% reduction in delayed appointments, and the company currently contracts with more than 300,000 patients. Lumata partners with physicians, payers, and health systems to provide between-visit assistance for chronic eye diseases such as diabetic retinopathy, macular degeneration, and glaucoma. New providers can try Lumata for 90 days with no upfront costs or EMR integration required. The company has raised more than $14.8MM in grant and venture funding to date. Lumata Health operates a human-led, intelligent eye care management platform that pairs patients with experienced eye care coordinators and JCAHPO-Certified Ophthalmic Assistants and Technicians to support care between ophthalmologist visits. The platform combines clinical and psychosocial elements with data and technology to improve adherence, education, and to address barriers such as transportation, medication refills, and injection-related anxiety. Lumata currently serves thousands of patients with vision-threatening chronic eye conditions, and data shows patients supported by the platform miss an average of 30% fewer clinic appointments. Its services are almost always free to patients and are reimbursed by most payers, including Medicare and often fully covered with supplemental insurance. The company plans to use new funding to advance predictive analytics, incorporate automated patient communication pathways, and expand offerings like pre-visit intake, prior authorization assistance, and pre-operative cataract education. Lumata was founded in 2017 by ophthalmologist Stephen R. Fransen, MD, and previously received more than $2MM in research funding from the National Eye Institute.

Led · Series A · Aug 2024

ArborXR offers a cloud-based platform that lets companies remotely manage AR and VR devices, install apps and content, control user access, and monitor device health in real time. The platform includes a web app for device setup and management, a directory of over 600 app developers, and support for unlimited devices across enterprise and education offerings. ArborXR's education product is used by over 420 educational institutions, and its enterprise service is used by more than 3,000 major companies; the company says its customer base tripled in the last year. The startup supports a wide range of headsets and AR glasses, including Apple Vision Pro, Meta Quest, HTC Vive, Pico, Magic Leap 2, Vuzix, RealWear and others. ArborXR sells subscription tiers (Starter $7/device/month, Essential $10/device/month, Enterprise $13/device/month) and offers a 30-day free trial. The company intends to use new funding to develop and scale the platform to meet growing demand and advance its long-term vision of XR transforming learning and work.